Yuzhe Sun

Mr. Yuzhe Sun

Auburn University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Yuzhe SunYuzhe Sun
Yuzhe Sun
AUAuburn University
Auburn University
To achieve the promise of stimuli-responsive drug delivery systems for the treatment of cancer, they should (1) avoid premature clearance; (2) accumulate in tumors and undergo endocytosis by cancer cells; and (3) exhibit appropriate stimuli-responsive release of the payload. It is challenging to address all of these requirements simultaneously. However, the numerous proof-of-concept studies addressing one or more of these requirements reported every year have dramatically expanded the toolbox available for the design of drug delivery systems. This review highlights recent advances in the targeting and stimuli-responsiveness of drug delivery systems. It begins with a discussion of nanocarrier types and an overview of the factors influencing nanocarrier biodistribution. On-demand release strategies and their application to each type of nanocarrier are reviewed, including both endogenous and exogenous stimuli. Recent developments in stimuli-responsive targeting strategies are also discussed. The remaining challenges and prospective solutions in the field are discussed throughout the review, which is intended to assist researchers in overcoming interdisciplinary knowledge barriers and increase the speed of development. This review presents a nanocarrier-based drug delivery systems toolbox that enables the application of techniques across platforms and inspires researchers with interdisciplinary information to boost the development of multifunctional therapeutic nanoplatforms for cancer therapy.

7 October 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
Yuzhe SunYuzhe Sun
Yuzhe Sun
AUAuburn University
Auburn University
We report a novel synthesis scheme to produce polydopamine (PDA) nanotubes using halloysite clay nanotubes (HNT) as a sacrificial template. Polydopamine nanotubes were fabricated via the formation of a polydopamine coating on HNT from a dopamine solution followed by template removal. Michael Addition was used to decorate the outer surface with polyethylene glycol. Removal of the template material resulted in a bilayered organic nanotube consisting of an inner layer of polydopamine adjacent to the lumen and an outer polyethylene glycol surface. The tubes had an aspect ratio of 5.3 ± 0.6, a diameter on the order of 70 nm, and wall thicknesses on the order of 15 nm. The PDA nanotubes exhibited photothermal conversion upon irradiation at near infrared wavelengths; a temperature increase of 30 °C was observed when a 250 μg ml−1 sample was subjected to 1 W cm−2 density irradiation at 808 nm wavelength. Analysis indicated that the prepared tubes had slightly higher photothermal conversion efficiency than PDA nanospheres. An antitumor drug, doxorubicin, was used as a model to test the potential for drug delivery of the organic nanotubes. The nanotubes exhibited higher loading capacities than PDA nanospheres and were capable of controlled release at pHs relevant to human serum and tumors (pH 7.4 and 5.0 respectively). Drug release rates varied as a function of system pH and application of near infrared irradiation. Release of doxorubicin was enhanced at a pH of 5.0, and retarded at a pH of 7.4. Irradiation with 808 nm wavelength light also increased the release of doxorubicin.


3 August 2022 in Langmuir
Verified
Journal Article
Closed access
Yuzhe SunYuzhe Sun
Yuzhe Sun
AUAuburn University
Auburn University

6 January 2022 in ACS Applied Polymer Materials
Verified
Journal Article
Closed access
ICIndika Chandrasiri
Indika Chandrasiri
MYMahesh Loku Yaddehige
Mahesh Loku Yaddehige
BLBo Li
Bo Li
Yuzhe SunYuzhe Sun
Yuzhe Sun
WMWilliam E. Meador
William E. Meador
Davita L. Watkins Davita L. Watkins
Davita L. Watkins

1 September 2019 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
Yuzhe SunYuzhe Sun
Yuzhe Sun
EDEdward Davis
Edward Davis
Since first reported in 2007, polydopamine synthesized in weakly alkaline condition has been extensively investigated. Among these studies, polydopamine nanospheres are commonly prepared as drug delivery nanoparticles for chemo-photothermal therapy. However, anisotropic nanostructures such as tubular shaped particles have higher specific surface area and enhanced biodistribution. But owing to the difficulty in preparation, they are rarely studied. In this study, polydopamine were fabricated into spherical and tubular shapes under weakly alkaline conditions. The nanospheres were formed in dopamine solution through a nanoprecipitation process, while hollow polydopamine nanotubes were obtained by forming a polydopamine coating on a sacrificial natural template, halloysite, in dopamine solution. Both the particles were modified with amino terminated polyethylene glycol via Michael addition. Morphology investigation showed distinct shape difference between the both nanoparticles. Under transmission electron microscopy, polydopamine nanoparticles have spherical morphology with diameters of 145-160 nm, while the nanotubes have high aspect ratios in the 4.7-5.9 range with lengths of 532-709 nm and diameters of 104-127 nm. Fourier transform infrared spectroscopy and thermogravimetric analysis were conducted to confirm both nanoparticle composition and that the template was removed completely. The photothermal effect was accessed under near infrared irradiation (808nm, 1W cm-2). The dispersions of the nanotubes, probably due to the higher specific surface, exhibited a higher temperature rise than the nanosphere dispersions. The nanotubes also displayed significantly higher loading capacity, nearly double of that for nanospheres, of an antitumor drug, doxorubicin. The release of the drug was enhanced by both acidic pH and infrared irradiation stimuli.